Short-seller Citron targets PLTR again, using a Databricks comparison to argue the stock is overvalued after its report sent ...

Palantir shares tumbled Tuesday afternoon, extending recent losses as a high-profile short seller fueled worries the stock ...

Citron Reseach’s founder Andrew Left, who once said crypto is “complete fraud,” is now facing fraud charges after the SEC accused him of profiting $16 million from market manipulation.

Andrew Left of Citron Research, which rose to fame for their role in exposing Valeant Pharmaceuticals, has taken to X to voice his concerns over the ruling in the Trump trial. Using Citron ...

Left's other company, Citron Research, on May 17, 2019, issued a negative tweet on Beyond Meat, which recommended that readers sell the stock and assign it a target price of $65 per share, at a ...

This Pure-Play Artificial Intelligence (AI) Stock Is Up 140% This Year but Trades at an Unsustainable Level, According to ...

Key Takeaways Palantir shares slid Wednesday to log their sixth straight day of declines, after a short seller raised ...